Takahashi, J.; Nagasawa, S.; Doi, M.; Takahashi, M.; Narita, Y.; Yamamoto, J.; Ikemoto, M.J.; Iwahashi, H.
In Vivo Study of the Efficacy and Safety of 5-Aminolevulinic Radiodynamic Therapy for Glioblastoma Fractionated Radiotherapy. Int. J. Mol. Sci. 2021, 22, 9762.
https://doi.org/10.3390/ijms22189762
AMA Style
Takahashi J, Nagasawa S, Doi M, Takahashi M, Narita Y, Yamamoto J, Ikemoto MJ, Iwahashi H.
In Vivo Study of the Efficacy and Safety of 5-Aminolevulinic Radiodynamic Therapy for Glioblastoma Fractionated Radiotherapy. International Journal of Molecular Sciences. 2021; 22(18):9762.
https://doi.org/10.3390/ijms22189762
Chicago/Turabian Style
Takahashi, Junko, Shinsuke Nagasawa, Motomichi Doi, Masamichi Takahashi, Yoshitaka Narita, Junkoh Yamamoto, Mitsushi J. Ikemoto, and Hitoshi Iwahashi.
2021. "In Vivo Study of the Efficacy and Safety of 5-Aminolevulinic Radiodynamic Therapy for Glioblastoma Fractionated Radiotherapy" International Journal of Molecular Sciences 22, no. 18: 9762.
https://doi.org/10.3390/ijms22189762
APA Style
Takahashi, J., Nagasawa, S., Doi, M., Takahashi, M., Narita, Y., Yamamoto, J., Ikemoto, M. J., & Iwahashi, H.
(2021). In Vivo Study of the Efficacy and Safety of 5-Aminolevulinic Radiodynamic Therapy for Glioblastoma Fractionated Radiotherapy. International Journal of Molecular Sciences, 22(18), 9762.
https://doi.org/10.3390/ijms22189762